{"data":{"id":815,"lang":"cs","title":"Znovuobjeveny lek na epilepsii z 50. let snizuje epizody spankove apnoe temer o 50 % a nabizi alternativu k CPAP","summary":"Evropska studie zjistila, ze lek na epilepsii sulthiam z 50. let snizuje preruseni dychani pri spankove apnoi az o 50 % a mohl by nahradit CPAP.","category":"science","category_label":"Věda","published_at":"2026-03-14T16:03:37Z","updated_at":"2026-03-14T16:03:37Z","url":"https://techtools.cz/tools/news/clanek/815-znovuobjeveny-lek-na-epilepsii-z-50-let-snizuje-epizody-spankove-apnoe-temer-o","api_url":"https://techtools.cz/news-api/v1/articles/815?lang=cs","markdown_url":"https://techtools.cz/news-api/v1/articles/815.md?lang=cs","image_url":"https://www.sciencealert.com/images/2026/03/SleepApnea.jpg","word_count":179,"reading_time_minutes":1,"sources":[{"url":"https://www.sciencealert.com/repurposed-drug-improves-sleep-apnea-by-up-to-50-in-clinical-trial","domain":"sciencealert.com"},{"url":"https://www.sciencedaily.com/releases/2026/03/260311004816.htm","domain":"sciencedaily.com"},{"url":"https://gizmodo.com/a-pill-for-sleep-apnea-clinical-trial-yields-promising-results-2000732380","domain":"gizmodo.com"}],"translation":{"lang":"en","id":793,"title":"Repurposed 1950s Epilepsy Drug Cuts Sleep Apnea Episodes by Nearly 50%, Offering Pill Alternative to CPAP","url":"https://techtools.cz/tools/news/article/793-repurposed-1950s-epilepsy-drug-cuts-sleep-apnea-episodes-by-nearly-50-offering","api_url":"https://techtools.cz/news-api/v1/articles/793?lang=en"},"content":"Evropska klinicka studie publikovana v casopise The Lancet zjistila, ze sulthiam - antikonvulzivum puvodni syntetizovane v 50. letech 20. stoleti k lecbe detske epilepsie - snizil preruseni dychani az o 50 % u pacientu se stredne tezkou az tezkou obstrukcni spankovou apnoi. Dvojite zaslepena studie zahrnula 240 ucastniku z peti zemi, pricemz ti, kteri uzivali davky 200-300 mg hodinu pred spanim, vykazovali o 30-50 % mene apnoickych epizod ve srovnani s placebem.\n\nVsechny davky sulthiamu prekonaly placebo ve vsech klicovych ukazatelich vcetne nocni hladiny kysliku v krvi a denni ospalosti. Vyzkumnici identifikovali 200 mg jako optimalni davku s dobrou rovnovahou mezi ucinnosti a minimalnimi vedlejsimi ucinky. Lek funguje tim, ze stabilizuje kontrolu dychani a zvysuje respiracni pohon, cimz snizuje pravdepodobnost kolapsu hornich cest dychacich behem spanku.\n\nZjisteni by mohla otevrit cestu k prvni tabletove lecbe obstrukcni spankove apnoe, ktera postihuje odhadem jednu miliardu lidi po celem svete. V soucasnosti je standardni lecbou pristroj CPAP, ktery mnoho pacientu povazuje za nepohodlny a prestava ho pouzivat. Vyzkumnici popsali sulthiam jako novou individualizovanou farmakoterapii, ktera resi zakladni dysfunkci dychacich cest misto spolehani na samotny ubytek hmotnosti."}}